12/2
08:09 am
flgt
Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]
Low
Report
Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]
11/14
07:22 am
flgt
Fulgent Genetics (NASDAQ:FLGT) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Fulgent Genetics (NASDAQ:FLGT) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
11/11
12:21 pm
flgt
Fulgent Genetics (NASDAQ:FLGT) had its price target raised by analysts at Piper Sandler from $21.00 to $30.00. They now have a "neutral" rating on the stock.
Low
Report
Fulgent Genetics (NASDAQ:FLGT) had its price target raised by analysts at Piper Sandler from $21.00 to $30.00. They now have a "neutral" rating on the stock.
11/11
09:11 am
flgt
Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Medium
Report
Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/8
07:05 pm
flgt
Fulgent Genetics Inc (FLGT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Upward ... [Yahoo! Finance]
Low
Report
Fulgent Genetics Inc (FLGT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Upward ... [Yahoo! Finance]
11/7
04:05 pm
flgt
Fulgent to Participate in Upcoming Conferences
Low
Report
Fulgent to Participate in Upcoming Conferences
11/7
07:05 am
flgt
Fulgent Reports Third Quarter 2025 Financial Results
High
Report
Fulgent Reports Third Quarter 2025 Financial Results
10/20
06:00 am
flgt
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference
Medium
Report
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference
10/16
07:00 am
flgt
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025
Low
Report
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025